In the wake of ongoing discussions regarding the future of the 10th European Framework Programme for Research and Development, Horizon Europe, the ECHoS consortium released its reflections on the challenges and opportunities it presents, alongside recommendations to the European Commission to maintain investment in cancer research.
The EU Mission on Cancer and Europe’s Beating Cancer Plan (EBCP) have both laid the groundwork for several ambitious and coordinated actions, bridging research, innovation, public policy and deployment. These efforts have led to the launch of important initiatives such as the European Cancer Patient Digital Centre (ECPDC), the Knowledge Centre on Cancer, the Network of Comprehensive Cancer Infrastructures, and the establishment of National Cancer Mission Hubs (NCMHs) across Member States and Associated Countries.
In a recent position paper, the consortium presents its vision for the future of the EU Mission on Cancer and the European Beating Cancer Plan. While some recommendations align closely with the consortium’s own objectives, reflecting its belief in their value for the broader European community, others extend beyond its immediate remit.
The paper argues that to ensure long-term sustainability and maximise the results of activities initiated under the EU Mission on Cancer and EBCP, the forthcoming Framework Programme for Research and Innovation 2028-2034 (FP10) must continue providing support to multisectoral actions capable of aligning Research, Innovation, Policy and Deployment in all member states across the entire cancer continuum.
According to the consortium, a robust and well-funded FP10 is critical to continue building European society, helping it bolster resilience across both research and health systems. The Position Report presents a strategic vision to strengthen Europe’s leadership in health promotion and cancer control, based on eight actionable recommendations designed to ensure long-lasting, equitable, and impactful progress.
Read the full Position Paper here. Endorse it here.
EATRIS is proud to support European projects working across the cancer research continuum and looks forward to collaborating with the consortium in the next phase of the ECHoS project.
